Treating mild hypertension.
作者信息
Breckenridge A
出版信息
Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):89-90. doi: 10.1136/bmj.291.6488.89.
Abstract
摘要
相似文献
1
Treating mild hypertension.治疗轻度高血压。
Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):89-90. doi: 10.1136/bmj.291.6488.89.
2
Further results of the MRC treatment trial for mild hypertension.轻度高血压医学研究委员会治疗试验的进一步结果。
Nephron. 1987;47 Suppl 1:111-4. doi: 10.1159/000184566.
3
The Medical Research Council Hypertension Trial: the smoking patient.医学研究委员会高血压试验：吸烟患者
Am Heart J. 1988 Jan;115(1 Pt 2):276-81. doi: 10.1016/0002-8703(88)90650-3.
4
Strokes in mild hypertension: diastolic rules.轻度高血压患者的中风：舒张压起决定作用。
Lancet. 1986 Oct 11;2(8511):854-6. doi: 10.1016/s0140-6736(86)92884-9.
5
Mild hypertension--a therapeutic dilemma. The results of the MRC trial in Britain.轻度高血压——治疗难题。英国医学研究委员会试验的结果。
Bibl Cardiol. 1987(42):48-55.
6
British MRC trial of treatment for mild hypertension--a more favorable interpretation.英国医学研究委员会轻度高血压治疗试验——一种更有利的解读
Am J Hypertens. 1991 Aug;4(8):723-4. doi: 10.1093/ajh/4.8.723.
7
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.医学研究委员会轻度高血压治疗试验：主要结果。医学研究委员会工作组
Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):97-104. doi: 10.1136/bmj.291.6488.97.
8
The mild hypertension dilemma: results of the British MRC trial.轻度高血压难题：英国医学研究委员会试验结果
J Clin Hypertens. 1986 Sep;2(3 Suppl):12S-21S.
9
Results of MRC (UK) trial of drug therapy for mild hypertension.英国医学研究委员会（MRC）轻度高血压药物治疗试验结果。
Clin Invest Med. 1987 Nov;10(6):616-20.
10
Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension.医学研究委员会轻度高血压治疗试验中的冠心病。医学研究委员会轻度高血压工作小组
Br Heart J. 1988 Mar;59(3):364-78. doi: 10.1136/hrt.59.3.364.
引用本文的文献
1
Institutionalisation and drug use in older adults in the US.美国老年人的机构收容与药物使用情况
Drugs Aging. 1993 May-Jun;3(3):232-7. doi: 10.2165/00002512-199303030-00004.
2
Guidelines for rational diuretic use in the elderly.老年人合理使用利尿剂指南。
Drugs. 1986;31 Suppl 4:202-6. doi: 10.2165/00003495-198600314-00024.
3
Failure to reduce cholesterol as explanation for the limited efficacy of antihypertensive treatment in the reduction of CHD. Examination of the evidence from six hypertension intervention trials.
Klin Wochenschr. 1987 Sep 1;65(17):828-32. doi: 10.1007/BF01727479.
4
Catching up the Europeans in preventing heart disease.在预防心脏病方面赶上欧洲人。
Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):271. doi: 10.1136/bmj.292.6515.271-a.
5
Experiences from hypertension trials. Impact of other risk factors.
Drugs. 1988;36 Suppl 3:9-20. doi: 10.2165/00003495-198800363-00005.
6
Antihypertensive treatment according to age, plasma renin and race.根据年龄、血浆肾素水平和种族进行的降压治疗。
Drugs. 1988 May;35(5):495-503. doi: 10.2165/00003495-198835050-00001.
7
Hypokalaemia with beta-blocker/thiazide combinations.β受体阻滞剂与噻嗪类药物联用导致的低钾血症
J R Coll Gen Pract. 1986 Jan;36(282):39.
本文引用的文献
1
Smoking and drug metabolism.吸烟与药物代谢。
Pharmacol Ther. 1981;15(2):207-21. doi: 10.1016/0163-7258(81)90042-5.
2
Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative drug therapies.利尿药对冠心病代谢危险因素的负面影响：可能的替代药物疗法。
Am J Cardiol. 1983 Feb 24;51(4):632-8. doi: 10.1016/s0002-9149(83)80200-8.
3
The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration.年龄、吸烟和甲状腺功能亢进对血浆普萘洛尔稳态浓度的影响。
Br J Clin Pharmacol. 1981 Jul;12(1):73-8. doi: 10.1111/j.1365-2125.1981.tb01857.x.
4
Which beta blocker?选用哪种β受体阻滞剂？
Br Med J (Clin Res Ed). 1983 Apr 2;286(6371):1085-8. doi: 10.1136/bmj.286.6371.1085.
5
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.欧洲老年高血压工作组试验的死亡率和发病率结果。
Lancet. 1985 Jun 15;1(8442):1349-54. doi: 10.1016/s0140-6736(85)91783-0.
6
Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.普萘洛尔在原发性高血压中降压作用的潜在机制。
N Engl J Med. 1976 Jul 8;295(2):68-73. doi: 10.1056/NEJM197607082950203.
7
Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol.
Clin Pharmacol Ther. 1977 Sep;22(3):299-308. doi: 10.1002/cpt1977223299.
Zotero 插件